Navigation Links
Solos Endoscopy, Inc. Receives Purchase Order from Connecticut Hospital
Date:11/6/2008

BOSTON, Nov. 6 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received a significant purchase order for laparoscopic instruments from the St. Mary's Hospital in Waterbury, CT. St. Mary's has been a client of Solos Endoscopy's for over 19 yrs and it has chosen to continue using the Company's surgical products.

Saint Mary's Hospital has played a vital role in the history of Greater Waterbury, providing nearly a century of service to the people of the Central Naugatuck Valley. Founded in 1907 by the Sisters of Saint Joseph of Chambery, Saint Mary's has been a beacon of healing and hope in Waterbury, Connecticut for more than 90 years. The hospital continues to expand its network of services, forging alliances with other key health care providers, and exploring new ways to comfort and cure.

"We are pleased to have St. Mary's remain a client of Solos Endoscopy for so long. We believe this truly validates our surgical products as some of the best on the market. As the Company looks toward the New Year, we will continue to grow our client base and maintain our business relationships with all our clients," stated Bob Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: http://www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Solos Endoscopy, Inc. Applauds American College of Surgeons Review of Advanced Breast Cancer Detection at 94th Annual Clinical Congress
2. Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information
3. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
4. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
5. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
6. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
7. InNexus Biotechnology Receives Patent Grants in Europe
8. Osteotech Receives FDA Clearance for its Next Generation Grafting Material
9. Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics
10. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
11. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... 2016 Research and Markets has announced the ... to their offering. The ... $29.3 billion in 2013. The market is expected to grow at ... to 2020, increasing from $50.6 billion in 2015 to $96.6 billion ... the forecast period (2015 to 2020) are discussed. As well, new ...
(Date:6/22/2016)... ... June 22, 2016 , ... Quantitative Radiology ... incubator and current participant in the Phase 1 Ventures program, is leveraging regional ... , Quantitative Radiology Solutions helps physicians make better treatment decisions by quantifying medical ...
(Date:6/22/2016)... ... June 22, 2016 , ... The Immigrant Journey ... and contributions to North Texas and the nation, recently held its annual luncheon ... to the civic and economic vitality of North Texas. Proceeds from the event ...
Breaking Biology Technology:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):